Quick Answer: To sell cosmetics in Canada, first confirm that the product is classified as a cosmetic, then review ingredient safety, manufacturing controls, claims and Canadian labelling. Manufacturers and importers must notify Health Canada within ten days after first sale using the Cosmetic Notification Form (CNF). Notification is not product approval. Build a coordinated launch plan with your supplier and Canadian importer rather than treating the CNF as the entire compliance process.
By mooyam_admin (MOOYAM editorial team). Last reviewed: 9 October 2026. Cover: AI-generated editorial illustration.
What should an international beauty brand do first?
Start with the product’s intended use and claims, not the shipping date. The same commercial category can contain products that follow different Canadian regulatory pathways. A brand should resolve classification before finalizing artwork, advertising and its importer’s instructions.
This guide is a launch-planning roadmap. It is not a field-by-field CNF tutorial or a promise that a particular formulation is compliant. The recommended business controls below help a brand organize evidence and handovers; the linked official guidance determines the applicable requirements.
Is the product a cosmetic, drug or natural health product?
Health Canada considers factors including representations, intended use, composition and product format when classifying products. Review the complete presentation: packaging, website descriptions, retailer listings and directions for use. Do not assume that calling a product “skincare” settles its classification. See Health Canada’s product classification guidance.
| Route question | What to establish | Project consequence |
|---|---|---|
| Cosmetic route | The product fits the cosmetic classification with its actual claims and intended use | Use the cosmetic safety, labelling and notification workstreams |
| Drug or natural health product route | The applicable classification and pathway need specialist review | Do not use a CNF as a substitute for the relevant requirements |
| Imported private label product | Confirm the manufacturer, importer and notification responsibilities | Organize a Canadian-specific evidence handover |
| Product also sold in another country | Review Canadian requirements independently | Foreign notifications or supplier certificates are not a Canadian launch decision |
Record the classification decision and its supporting reasoning in your project file. If claims change later, reopen that review. This is a recommended control to prevent commercial edits from silently changing the regulatory assumptions.
What must be ready before the first sale?
The Canadian cosmetic framework includes the Food and Drugs Act and Cosmetic Regulations. Health Canada’s regulatory overview explains safety and sanitary manufacturing expectations, as well as other legislation that may apply. These obligations should be addressed before launch; they are not created only after notification.
| Workstream | Evidence to organize | Release check |
|---|---|---|
| Product identity | Formula version, intended use, format and claims register | The reviewed product matches the one to be sold |
| Ingredients | Complete composition and applicable restrictions review | Conditions, warnings and concentrations have been considered |
| Quality and safety | Relevant manufacturing, testing and packaging evidence | The evidence applies to the actual finished product |
| Canadian label | Final production artwork and ingredient declaration | Language, contact, quantity and warning requirements have been checked |
| Notification readiness | Manufacturer/importer details and accurate product data | The owner of the CNF submission and deadline is identified |
| Post-launch control | Complaint routing, change log and document ownership | The team can update information and respond to regulatory questions |
Do not turn this checklist into a universal testing prescription. Evidence needs differ with formulation, intended use, packaging and available information. Ask the appropriate reviewer to identify gaps rather than buying a generic package because it is labelled “international compliance.”
How should the formula be reviewed?
The Cosmetic Ingredient Hotlist policy explains prohibited and restricted ingredients. The Hotlist is not exhaustive: absence from it does not establish that an ingredient or finished product is safe. Review applicable concentration, use and warning conditions rather than checking ingredient names alone.
As a recommended supplier handover, request quantitative composition through an appropriate confidential channel, ingredient specifications and relevant supporting reports. Ensure the Canadian reviewer has enough information to assess the exact formula. A retail INCI list is useful but does not necessarily answer concentration-dependent questions.
If the supplier offers several fragrance options or packaging combinations, give each version a clear identifier. Do not attach one product’s evidence to another option without checking its relevance. Keep approved versions distinguishable from experimental samples.
How does Canadian labelling affect the launch?
Use Health Canada’s industry labelling guide for the final artwork review. Product identity and net quantity generally require English and French, while ingredient declarations follow specific naming rules. Review the applicable contact information, cautions, legibility and package configuration; do not translate the entire label mechanically and assume the result complies.
Current fragrance-allergen dates matter
At this review date, the initial 24-allergen requirement has applied since 12 April 2026. The expanded list applies to new cosmetics from 1 August 2026, with the corresponding existing-product deadline on 1 August 2028. The relevant thresholds are above 0.01% for rinse-off products and above 0.001% for leave-on products. Confirm which category and transition apply before approving artwork.
A new launch in October 2026 should not simply assume it can wait until 2028. Ask your reviewer to verify the product’s status and the current lists. Have the supplier provide the data needed for that assessment, including contributions from relevant ingredients where applicable.
When is the Cosmetic Notification Form due?
Manufacturers and importers must notify Health Canada within ten days after the first sale. Health Canada states that submitting a CNF is not approval, confirmation of classification or evidence of full compliance. Notification has no fee. Consult the official cosmetic notification requirements.
Prepare the data before launch even though the legal notification deadline follows first sale. A practical plan names one submission coordinator, records the actual first-sale date and keeps a copy of the submitted information. Avoid relying on an informal assumption that a distributor or factory has already handled it.
A practical market-entry sequence
- Define the product brief. Record target users, intended use, claims and sales channels.
- Resolve classification. Address ambiguous claims before investing in packaging.
- Identify the Canadian importer and submission owner. Confirm who gathers data, submits and maintains records.
- Review the exact formulation. Assemble the relevant ingredient and safety evidence.
- Approve Canadian artwork. Check the production proof and all consumer-facing representations.
- Coordinate stock release and first sale. Use a documented decision rather than equating shipment with readiness.
- Submit the CNF on time. Preserve the submission record and manage subsequent changes.
- Maintain oversight. Route complaints and review formula, packaging or claims changes before using revised materials.
This sequence is a recommended project workflow, not a guaranteed approval timetable. No single number of days can represent every product’s preparation. Distinguish production time, artwork changes, evidence collection and regulatory review in your launch schedule.
Common mistakes that delay a Canadian launch
- Using the notification as a safety certificate. Keep administrative submission and product compliance separate.
- Leaving data collection until after first sale. Missing manufacturer or ingredient information can create avoidable deadline pressure.
- Copying a foreign label unchanged. Review Canadian language and ingredient requirements independently.
- Ignoring retailer claims. Review claims outside the package as well as the supplier’s product sheet.
- Failing to identify the reviewed version. Formula and artwork changes need a controlled handover.
What can the manufacturer provide, and what must the brand arrange?
A manufacturer can supply agreed ingredient information, COA and SDS where relevant, manufacturing records, available stability or microbiological reports, packaging compatibility information and batch documentation. The exact scope should be confirmed rather than assumed. The brand coordinates market-specific claims, label decisions and the importer relationship; the legally responsible parties retain their applicable obligations.
For a broader document handover, see our private label compliance handover guide, noting that its legal requirements concern the UK and are not Canadian rules. Brands operating internationally can also compare their planning approach with the UK market-entry guide; do not reuse either country’s route without a local review.
FAQ
Does Health Canada approve cosmetics through the CNF?
No. The notification is not approval or confirmation that the product meets every requirement.
Can an international brand sell first and consider safety later?
No. The notification timing does not postpone the applicable safety, labelling and other product obligations.
Is a factory certificate sufficient for Canadian market entry?
No. Review the finished product and Canadian requirements rather than relying on a general certificate.
Can English-only artwork be used without review?
Do not assume so. The official guide sets out bilingual and other label requirements, with specific rules and exceptions.
Who should coordinate the launch?
The brand should establish an explicit workflow with the manufacturer and Canadian importer, including who submits the notification and maintains accurate information.
Discuss your Canadian-market manufacturing brief
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Review our OEM/ODM services and contact us with the intended product, packaging, market and documentation scope. Market-specific compliance decisions should be reviewed by the appropriate professionals.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market. This article is general information, not product-specific legal advice.